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In this issue of Structure, Segrest et al. (2015) present a novel picture for the ABCA1-mediated lipid loading of
lipid-poor apoA-I.Cardiovascular diseases (CVDs) are glob-
ally the leading cause of death. The most
common cause of CVD is atherosclerosis
characterized by thickening of the arterial
wall as a result of a buildup of fatty
material. The fatty material in the arterial
wall is almost solely derived from
low-density lipoprotein (LDL) particles,
thus, not surprisingly, there is a direct
causal link between CVD and LDL-
cholesterol concentration in blood circu-
lation (Voight et al., 2012). Meanwhile,
high-density lipoprotein (HDL; Figure 1)
particles are considered to be cardio-pro-
tective because they can remove excess
LDL-derived cholesterol from the arterial
walls. Although it has been shown that
HDL-cholesterol (HDL-C) levels in blood
are inversely correlated with the risk of,
for example, myocardial infarction, recent
clinical trials have failed to show that
elevating HDL-C would decrease deaths
(Rader and Tall, 2012). Additionally,
genome-wide association studies have
raised doubts against the causal relation-
ship between HDL-C and atherosclerosis
(Voight et al., 2012).
These findings highlight the urgent
need to reveal the critical steps in the
biogenesis of HDL particles. To gain that
knowledge, one should understand the
molecular scale phenomena associated
with the different metabolic steps of
HDL. Unravelling such details in the nano-
scale is not particularly easy, but recent
methodological advances in molecular
simulation technologies and computing
power have rendered it possible (Koivu-
niemi et al., 2012, 2013; Murtola et al.,
2011; Yetukuri et al., 2010), thereby com-
plementing experiments.
One of the most important steps in
reverse cholesterol transport (RCT), that
is the movement of cholesterol from
non-hepatic peripheral tissues back toliver for degradation, is the HDL-mediated
efflux of excess cholesterol from the cells.
Despite intense interest on RCT, one of
the major open questions is how the
liver-secreted apolipoprotein A1 (apoA-I)
molecules harvest the cellular cholesterol
assisted by ABCA1, the ATP-binding
cassette transporter and the major regu-
lator of cellular cholesterol. The aim is to
understand how the ABCA1 transporter
interacts with lipid-poor apoA-I and loads
it up with phospholipids and cholesterol
to form a nascent HDL particle.
Recent findings indicate that an ABCA1
dimer is needed for the interaction with
apoA-I (Nagata et al., 2013). However,
this study does not explain how the
loading of lipids takes place and what
physical forces drive it. The authors pro-
posed an interesting hypothesis that
the formation of ABCA1 dimers occurs
after cholesterol and phospholipids are
reserved within the large extracellular do-
mains (ECDs) of ABCA1 or in their vicinity.
After the formation of an ABCA1 dimer,
diffusion would then halt because of
interactions with the cytoskeleton. After
immobilization of the dimer, apoA-I pro-
teins would bind to the dimer and the lipid
loading would begin. However, if this
hypothesis is correct, the molecular
details along these steps are still not
known; in particular, what is the physical
basis of how apoA-I extracts lipids from
the ECDs of ABCA1 or from their
neighborhood.
Another view, which does not neces-
sarily compete with the above picture,
states that ABCA1 generates an unequal
molecular packing density across the
plasma membrane, followed by forma-
tion of an exovesiculated domain to
which apoA-I can bind with high affinity
(Vedhachalam et al., 2007). In this model,
apoA-I first attaches to the ABCA1 trans-Structure 23, July 7, 2015porter and after the formation of a
highly curved membrane surface next to
ABCA1, apoA-I hops on the curved sur-
face. The surface containing apoA-I
would then somehow transform to a
nascent HDL particle.
In this issue, Segrest et al. (2015) shed
light on the mechanism of how lipid-poor
apoA-I is able to harvest cellular choles-
terol and phospholipids. Through a
combination of computational and exper-
imental approaches, they show that an
increased outer lipid monolayer surface
density results in pleating of the outer
monolayer to form membrane-attached
discoidal bilayers. In addition, they
demonstrate that the attachment of
apoA-I to the outer lipid surface facili-
tates the outer lipid monolayer pleating.
Segrest et al. (2015) further show that
the pleating morphology is influenced by
the concentration of membrane choles-
terol and that amphiphatic 4F peptides
(apoA-I mimetic peptides with therapeutic
potential) are also able to form discoidal
bilayer pleats resembling apoA-I-induced
protrusions.
The view presented by Segrest et al.
(2015) is novel and very interesting.
Additionally, it raises new and exciting
questions. How is the extracellular lipid
reservoir or the transmembrane density
gradient entrapped so that it does not
vanish to the surrounding medium? How
is lipid flip-flop between the lipid leaflets
hindered in and around this region? How
are the large extracellular domains of
ABCA1 transporters able to confine a
small patch of a plasma membrane or
are there other lipid-mediated ways to
achieve it? What is the conformation of
apoA-I proteins when they are attached
to an ABCA1 dimer complex and is the
lipid loading of the ECDs of ABCA1 a pre-
requisite for the attachment of apoA-Is?ª2015 Elsevier Ltd All rights reserved 1153
Figure 1. Spherical HDL
The work by Segrest et al. (2015) elucidates how nascent HDL is lipidated, the final outcome of the pro-
cess being largely the HDL particle shown in the figure (diameter 8 nm). Shown here is (left) a spherical
HDL in full, complemented by (right) a cross-section of the same particle. Color code: ApoA-I proteins
(purple for a helices, pink for 310 helices, cyan for turns, and white for coil), phospholipids (blue),
cholesterol (green), and cholesterol esters (orange). For simplicity, triglycerides also residing in the hydro-
phobic core of lipoprotein particles are not accounted for in the model. Visualization by Topi Karilainen/
Vattulainen group.
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PreviewsIn addition to the biogenesis of HDL
particles, the formation of intracellular
lipid droplets (LDs) is also a poorly
understood process. Analogously to the
composition of lipoproteins, cellular LDs
are comprised of a phospholipid mono-
layer decorated by different proteins,
surrounding a hydrophobic core that
consists of triglycerides and cholesterol
esters. The precise mechanism and the
driving force of LD biogenesis remain
mostly unknown (Wilfling et al., 2014). In
the light of the study by Segrest et al.
(2015), it is probable that amphiphilic pep-
tides (e.g., perilipins) are able to facilitate
the budding from the endoplasmic reticu-
lum (ER) membrane by attaching to the1154 Structure 23, July 7, 2015 ª2015 Elsevicurved surface generated by aggregation
of triglycerides between the ER mem-
brane leaflets.
In summary, Segrest et al. (2015)
describe how the lipid loading of apoA-I
may occur via ABCA1 transporters by
the generation of an isolated pressurized
lipid monolayer, from which the nascent
HDL particles are budded with the help
of apoA-I. Hopefully, the current study
will also help to further understand the for-
mation of intracellular lipid droplets. The
proposed model is expected to guide
future experiments to solve the molecular
mechanism of HDL biogenesis in detail. In
the end, this knowledge may provide us
with a basis for systematic manipulationer Ltd All rights reservedof the RCT, which in turn could generate
new treatments against CVD.
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